🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 7 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/03/2024 10,15 10,21 9,85 9,87 -2,66% 3,60% 5.772.800
15/03/2024 10,20 10,33 10,02 10,14 -0,88% 3,04% 7.649.800
14/03/2024 10,56 10,63 10,10 10,23 -3,67% 5,07% 5.556.500
13/03/2024 10,33 10,65 10,21 10,62 +3,21% 4,26% 6.202.900
12/03/2024 10,44 10,52 10,23 10,29 -1,44% 2,73% 5.725.400
11/03/2024 10,61 10,78 10,41 10,44 -2,25% 3,53% 5.756.600
08/03/2024 11,21 11,23 10,62 10,68 -4,22% 5,44% 7.870.200
07/03/2024 11,60 11,61 11,00 11,15 -3,63% 5,26% 7.051.700
06/03/2024 11,77 11,80 11,52 11,57 -0,26% 2,38% 3.689.900
05/03/2024 11,46 11,70 11,45 11,60 +1,05% 2,18% 4.222.500
04/03/2024 11,88 12,00 11,42 11,48 -2,46% 4,88% 4.954.600
01/03/2024 11,50 11,88 11,50 11,77 +2,88% 3,30% 5.136.000
29/02/2024 11,85 11,89 11,33 11,44 -2,31% 4,73% 5.232.800
28/02/2024 11,71 11,77 11,54 11,71 -0,76% 1,96% 3.740.700
27/02/2024 11,66 11,81 11,57 11,80 +0,85% 2,10% 4.273.400
26/02/2024 11,59 11,88 11,56 11,70 +0,86% 2,76% 4.608.500
23/02/2024 11,36 11,68 11,28 11,60 +2,11% 3,52% 3.398.900
22/02/2024 11,61 11,67 11,33 11,36 -1,56% 2,93% 5.079.600
21/02/2024 11,45 11,59 11,32 11,54 +0,00% 2,40% 3.735.600
20/02/2024 11,65 11,73 11,47 11,54 -0,43% 2,27% 4.315.200
16/02/2024 11,29 11,61 11,28 11,59 +1,22% 2,92% 4.367.900
15/02/2024 11,61 11,68 11,31 11,45 +1,15% 3,19% 6.596.800
14/02/2024 10,80 11,36 10,80 11,32 +4,81% 5,19% 6.365.600
13/02/2024 10,87 11,02 10,54 10,80 -0,64% 4,42% 6.202.400
12/02/2024 10,79 10,90 10,67 10,87 +0,56% 2,18% 6.798.400
09/02/2024 10,84 11,12 10,69 10,81 +2,27% 3,96% 4.607.900
08/02/2024 10,42 10,62 10,31 10,57 +1,73% 2,98% 7.159.700
07/02/2024 10,35 10,48 10,26 10,39 +0,87% 2,13% 4.638.200
06/02/2024 10,03 10,32 9,97 10,30 +2,79% 3,44% 3.481.000
05/02/2024 9,77 10,06 9,69 10,02 +1,31% 3,79% 3.770.800